Mozobil (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Mozobil drug offered from sanofi-aventis U.S. LLC. This Hematopoietic Stem Cell Mobilizer [EPC],Increased Hematopoietic Stem Cell Mobilization [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | PLERIXAFOR |
SUBSTANCE NAME: | PLERIXAFOR |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Hematopoietic Stem Cell Mobilizer [EPC],Increased Hematopoietic Stem Cell Mobilization [PE] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-09-01 |
END MARKETING DATE: | 0000-00-00 |
Mozobil HUMAN PRESCRIPTION DRUG Details:
Item Description | Mozobil from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 24(mg/1.2mL) |
START MARKETING DATE: | 2013-09-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0024-5862_88f93cdb-26f8-414a-8ad6-96ca0d098ec1 |
PRODUCT NDC: | 0024-5862 |
APPLICATION NUMBER: | NDA022311 |
Other PLERIXAFOR Pharmaceutical Manufacturers / Labelers: